Non-Communicable Disease Prevention : Best Buys, Wasted Buys and Contestable Buys.

Yazar:Isaranuwatchai, Wanrudee
Katkıda bulunan(lar):Archer, Rachel A | Teerawattananon, Yot
Materyal türü: KonuKonuYayıncı: Cambridge : Open Book Publishers, 2019Telif hakkı tarihi: �2019Tanım: 1 online resource (222 pages)İçerik türü:text Ortam türü:computer Taşıyıcı türü: online resourceISBN: 9781783748655Konu(lar): Medicine, PreventiveTür/Form:Electronic books.Ek fiziksel biçimler:Print version:: Non-Communicable Disease PreventionDDC sınıflandırma: 613 LOC classification: RA425 | .N66 2019Çevrimiçi kaynaklar: Click to View
İçindekiler:
Intro -- Contents -- Forewords -- Acknowledgements -- Notes on Contributors -- 1. Introduction -- 1.1 Non-Communicable Disease -- 1.2 Best, Wasted and Contestable Buys -- 1.3 Definitions and Central Ideas -- Box 1.1 Definitions of Basic Terminology Used in Economic Evaluation -- 1.4 The Cost-Effectiveness Plane -- 1.5 The Story of This Book -- 1.6 The Project and Its Output -- 1.7 The Project Journey -- 1.8 Target Audience -- 2. Non-Communicable Diseases, NCD Program Managers and the Politics of Progress -- 2.1 Background -- 2.2 Methods for Interviews and Analysis -- 2.3 Institutions: NCD Managers, NCD Units and Ministries of Health -- 2.4 Interests: Stakeholders and Power -- 2.5 Ideas: Evidence, Knowledge and Values -- 2.6 Discussion -- 2.7 Limitations -- 2.8 Conclusions and Recommendations -- 3. Framework for Implementing Best Buys and Avoiding Wasted Buys -- 3.1 Consideration One -- 3.2 Consideration Two -- 3.3 Consideration Three -- 3.4 Consideration Four -- 3.5 Consideration Five -- 3.6 The SEED Tool in Practice -- 4. Best Buys -- 4.1 Introduction -- 4.1.1 Background -- 4.1.2 What This Chapter Offers -- 4.2 Determining Important Contextual Factors in NCD Prevention -- 4.3 Policymaking Challenges and Cost-Effectiveness Data -- 4.4 Investigating Case Studies -- Case Study 4.4.1 Cardiovascular screening in Sri Lanka -- Case Study 4.4.2 Prevention and control of cervical cancer in Cambodia -- Case Study 4.4.3 Sugar-Sweetened Beverage (SSB) taxes -- 4.5 Discussion -- 4.6 Conclusion -- 5. Wasted Buys -- 5.1 Introduction -- 5.1.1 What Are 'Wasted Buys'? -- 5.1.2 The 'Area of Uncertainty' -- 5.2 Exploring Wasted Buys in Low- and Middle-Income Countries (LMICs) -- A. Cochrane Collaboration Database -- B. The Global Health Cost-Effectiveness Analysis (GH CEA) Registry -- C. Disease Control Priorities (DCP).
Case Study 5.2.1 Leveling up: Mass-media campaigns for prevention of NCDs -- Case Study 5.2.2 Overseas and over here: Cost-effectiveness of medical primary prevention strategies to reduce the risk of cardiovascular disease (CVD) in Tanzania -- Case Study 5.2.3 Streamlining health policy for health gains: Diabetes screening in Thailand and Indonesia -- Case Study 5.2.4 Back to basics: Drug testing in Bhutan -- 5.3 Common Features of Wasted Buys -- 5.3.1 The Fallacy that Prevention Interventions Are Always Best Buys -- 5.3.2 One Size Seldom Fits All in International Guidelines -- 5.3.3 Policy-Based Evidence Versus Evidence-Based Policy -- 5.3.4 Selective Implementation of Interventions -- 5.3.5 Low CE Threshold Used for Decision-Making -- 5.4 Recommendations -- 6. Assessing the Transferability of Economic Evaluations: A Decision Framework -- 6.1 Introduction -- 6.2 Review of the Literature -- 6.3 A Decision Framework for Identifying Locally-Relevant Best and Wasted Buys -- 6.3.1 Background -- 6.3.2 A Decision Framework and a Transferability Assessment Checklist -- Step 1: Initial Assessment of Study Design -- A. Study Perspective -- B. Intervention and its Comparator(s) -- C. Time Horizon -- D. Discounting -- E. Study Quality -- Step 2: Data Transferability Assessment -- A. Baseline Risk (Disease Profile) -- B. Treatment Effects (Clinical Information) -- C. Unit Costs/Prices -- D. Resource Utilization -- E. Health-State Preference Weight -- 6.4 Worked Example: Assessing Transferability of Best Buy Interventions for Diabetes Prevention and Management in Kenya -- 6.4.1 Background and Rationale -- 6.4.2 Evaluator's Guideline on Economic Evaluation -- 6.4.3 Transferability Assessment Process -- 6.4.4 Transferability Assessment Results -- 6.5 Using the Impact Inventory -- 6.6 Conclusion and Next Steps -- 7. Finding the Best Evidence.
7.1 Determining the Impact of Behavior Change on NCDs Through Research -- Case Study 7.1.1 Knowledge growth: A case study of low-calorie sweeteners -- 7.2 Types of Study Design -- 7.3 Quality Assessment of Studies/Evidence -- 7.4 Types of Evidence Synthesis -- Case Study 7.4.1 Efficacy of lifestyle interventions and effect of lifestyle factors on the risk of type 2 diabetes mellitus, cardiovascular diseases and hypertension: An umbrella review -- 7.5 Role of Environmental Interventions in Changing Health Behavior -- 7.6 Conclusion -- 8. Cross-Sectoral Policies to Address Non-Communicable Diseases -- 8.1 Introduction -- 8.2 Why Are Cross-Sectoral Policies So Challenging? -- 8.3 Analytic Framework -- 8.4 Institutional Requirements -- 8.5 Types of Cross-Sectoral Policies -- Case Study 8.5.1. The public catering decree in Hungary: Intersectoral public-health action to improve nutrition and address social inequalities with a binding legal instrument -- Context -- Instrument -- Making It Happen -- Impact -- Case Study 8.5.2. Employing people with disabilities in Croatia: intersectoral public health action for an inclusive labor market -- Context -- Instrument -- Making It Happen -- Impact -- 8.6 Conclusions -- 8.7 Analytical Appendix -- 9. Deliberative Processes in Decisions about Best Buys, Wasted Buys and Contestable Buys: Uncertainty and Credibility -- 9.1 Introduction -- 9.2 Criteria, Opportunity Costs and Social Value Judgments: A Role for Deliberation -- 9.3 Deliberation Contrasted with Algorithms -- 9.4 Evidence -- Box 9.1 Categories of Evidence -- 9.5 Uncertainty -- 9.6 Credibility -- 9.7 Some Characteristics of Deliberative Processes -- 9.7.1 Case Study: The (then) National Institute for Clinical Excellence (England and Wales) -- 9.8 Conclusions -- 10. Summing Up -- Glossary of Abbreviations -- List of Illustrations and Tables -- Chapter 1.
Chapter 2 -- Chapter 3 -- Chapter 4 -- Chapter 5 -- Chapter 6 -- Chapter 7 -- Chapter 9 -- End page.
Özet: This book is written for the benefit of the global health community, and is primarily targeted at those individuals who are involved in NCD programs. This book will also be of interest to NCD champions, policy advocates, and educators spearheading the movement for increased visiblity of NCDs.
Bu kütüphanenin etiketleri: Kütüphanedeki eser adı için etiket yok. Etiket eklemek için oturumu açın.
    Ortalama derecelendirme: 0.0 (0 oy)
Bu kayda ilişkin materyal yok

Intro -- Contents -- Forewords -- Acknowledgements -- Notes on Contributors -- 1. Introduction -- 1.1 Non-Communicable Disease -- 1.2 Best, Wasted and Contestable Buys -- 1.3 Definitions and Central Ideas -- Box 1.1 Definitions of Basic Terminology Used in Economic Evaluation -- 1.4 The Cost-Effectiveness Plane -- 1.5 The Story of This Book -- 1.6 The Project and Its Output -- 1.7 The Project Journey -- 1.8 Target Audience -- 2. Non-Communicable Diseases, NCD Program Managers and the Politics of Progress -- 2.1 Background -- 2.2 Methods for Interviews and Analysis -- 2.3 Institutions: NCD Managers, NCD Units and Ministries of Health -- 2.4 Interests: Stakeholders and Power -- 2.5 Ideas: Evidence, Knowledge and Values -- 2.6 Discussion -- 2.7 Limitations -- 2.8 Conclusions and Recommendations -- 3. Framework for Implementing Best Buys and Avoiding Wasted Buys -- 3.1 Consideration One -- 3.2 Consideration Two -- 3.3 Consideration Three -- 3.4 Consideration Four -- 3.5 Consideration Five -- 3.6 The SEED Tool in Practice -- 4. Best Buys -- 4.1 Introduction -- 4.1.1 Background -- 4.1.2 What This Chapter Offers -- 4.2 Determining Important Contextual Factors in NCD Prevention -- 4.3 Policymaking Challenges and Cost-Effectiveness Data -- 4.4 Investigating Case Studies -- Case Study 4.4.1 Cardiovascular screening in Sri Lanka -- Case Study 4.4.2 Prevention and control of cervical cancer in Cambodia -- Case Study 4.4.3 Sugar-Sweetened Beverage (SSB) taxes -- 4.5 Discussion -- 4.6 Conclusion -- 5. Wasted Buys -- 5.1 Introduction -- 5.1.1 What Are 'Wasted Buys'? -- 5.1.2 The 'Area of Uncertainty' -- 5.2 Exploring Wasted Buys in Low- and Middle-Income Countries (LMICs) -- A. Cochrane Collaboration Database -- B. The Global Health Cost-Effectiveness Analysis (GH CEA) Registry -- C. Disease Control Priorities (DCP).

Case Study 5.2.1 Leveling up: Mass-media campaigns for prevention of NCDs -- Case Study 5.2.2 Overseas and over here: Cost-effectiveness of medical primary prevention strategies to reduce the risk of cardiovascular disease (CVD) in Tanzania -- Case Study 5.2.3 Streamlining health policy for health gains: Diabetes screening in Thailand and Indonesia -- Case Study 5.2.4 Back to basics: Drug testing in Bhutan -- 5.3 Common Features of Wasted Buys -- 5.3.1 The Fallacy that Prevention Interventions Are Always Best Buys -- 5.3.2 One Size Seldom Fits All in International Guidelines -- 5.3.3 Policy-Based Evidence Versus Evidence-Based Policy -- 5.3.4 Selective Implementation of Interventions -- 5.3.5 Low CE Threshold Used for Decision-Making -- 5.4 Recommendations -- 6. Assessing the Transferability of Economic Evaluations: A Decision Framework -- 6.1 Introduction -- 6.2 Review of the Literature -- 6.3 A Decision Framework for Identifying Locally-Relevant Best and Wasted Buys -- 6.3.1 Background -- 6.3.2 A Decision Framework and a Transferability Assessment Checklist -- Step 1: Initial Assessment of Study Design -- A. Study Perspective -- B. Intervention and its Comparator(s) -- C. Time Horizon -- D. Discounting -- E. Study Quality -- Step 2: Data Transferability Assessment -- A. Baseline Risk (Disease Profile) -- B. Treatment Effects (Clinical Information) -- C. Unit Costs/Prices -- D. Resource Utilization -- E. Health-State Preference Weight -- 6.4 Worked Example: Assessing Transferability of Best Buy Interventions for Diabetes Prevention and Management in Kenya -- 6.4.1 Background and Rationale -- 6.4.2 Evaluator's Guideline on Economic Evaluation -- 6.4.3 Transferability Assessment Process -- 6.4.4 Transferability Assessment Results -- 6.5 Using the Impact Inventory -- 6.6 Conclusion and Next Steps -- 7. Finding the Best Evidence.

7.1 Determining the Impact of Behavior Change on NCDs Through Research -- Case Study 7.1.1 Knowledge growth: A case study of low-calorie sweeteners -- 7.2 Types of Study Design -- 7.3 Quality Assessment of Studies/Evidence -- 7.4 Types of Evidence Synthesis -- Case Study 7.4.1 Efficacy of lifestyle interventions and effect of lifestyle factors on the risk of type 2 diabetes mellitus, cardiovascular diseases and hypertension: An umbrella review -- 7.5 Role of Environmental Interventions in Changing Health Behavior -- 7.6 Conclusion -- 8. Cross-Sectoral Policies to Address Non-Communicable Diseases -- 8.1 Introduction -- 8.2 Why Are Cross-Sectoral Policies So Challenging? -- 8.3 Analytic Framework -- 8.4 Institutional Requirements -- 8.5 Types of Cross-Sectoral Policies -- Case Study 8.5.1. The public catering decree in Hungary: Intersectoral public-health action to improve nutrition and address social inequalities with a binding legal instrument -- Context -- Instrument -- Making It Happen -- Impact -- Case Study 8.5.2. Employing people with disabilities in Croatia: intersectoral public health action for an inclusive labor market -- Context -- Instrument -- Making It Happen -- Impact -- 8.6 Conclusions -- 8.7 Analytical Appendix -- 9. Deliberative Processes in Decisions about Best Buys, Wasted Buys and Contestable Buys: Uncertainty and Credibility -- 9.1 Introduction -- 9.2 Criteria, Opportunity Costs and Social Value Judgments: A Role for Deliberation -- 9.3 Deliberation Contrasted with Algorithms -- 9.4 Evidence -- Box 9.1 Categories of Evidence -- 9.5 Uncertainty -- 9.6 Credibility -- 9.7 Some Characteristics of Deliberative Processes -- 9.7.1 Case Study: The (then) National Institute for Clinical Excellence (England and Wales) -- 9.8 Conclusions -- 10. Summing Up -- Glossary of Abbreviations -- List of Illustrations and Tables -- Chapter 1.

Chapter 2 -- Chapter 3 -- Chapter 4 -- Chapter 5 -- Chapter 6 -- Chapter 7 -- Chapter 9 -- End page.

This book is written for the benefit of the global health community, and is primarily targeted at those individuals who are involved in NCD programs. This book will also be of interest to NCD champions, policy advocates, and educators spearheading the movement for increased visiblity of NCDs.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2022. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.

There are no comments on this title.

yorum yazmak için.

Ziyaretçi Sayısı

Destekleyen Koha